US Stock MarketDetailed Quotes
KYTX Kyverna Therapeutics
- 5.230
- -0.020-0.38%
Close Sep 27 16:00 ET
- 5.230
- 0.0000.00%
Post 20:02 ET
225.66MMarket Cap-2462P/E (TTM)
5.350High5.150Low411.79KVolume5.250Open5.250Pre Close2.15MTurnover1.84%Turnover RatioLossP/E (Static)43.15MShares35.06052wk High0.68P/B117.01MFloat Cap5.15052wk Low--Dividend TTM22.37MShs Float35.060Historical High--Div YieldTTM3.81%Amplitude5.150Historical Low5.231Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Kyverna Therapeutics Stock Forum
Kyverna's KYV-101 Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Refractory Stiff-Person Syndrome
Kyverna Therapeutics (KYTX) has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for KYV-101, its autologous CD19 CAR T-cell therapy, in treating refractory stiff-person syndrome. This designation, based on positive clinical outcomes in Germany, allows Kyverna to receive expert guidance on efficient ...
No comment yet